SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-23-194691
Filing Date
2023-07-26
Accepted
2023-07-26 16:56:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFM14A d529654ddefm14a.htm DEFM14A 2484247
2 GRAPHIC g529654g01a76.jpg GRAPHIC 37044
3 GRAPHIC g529654g01p01.jpg GRAPHIC 180393
4 GRAPHIC g529654g02p02.jpg GRAPHIC 146798
5 GRAPHIC g529654g54p03.jpg GRAPHIC 58180
  Complete submission text file 0001193125-23-194691.txt   3055626
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-38459 | Film No.: 231114255
SIC: 2836 Biological Products, (No Diagnostic Substances)